[go: up one dir, main page]

JP2003126268A - Biological tissue adhesive applicator - Google Patents

Biological tissue adhesive applicator

Info

Publication number
JP2003126268A
JP2003126268A JP2001323890A JP2001323890A JP2003126268A JP 2003126268 A JP2003126268 A JP 2003126268A JP 2001323890 A JP2001323890 A JP 2001323890A JP 2001323890 A JP2001323890 A JP 2001323890A JP 2003126268 A JP2003126268 A JP 2003126268A
Authority
JP
Japan
Prior art keywords
biological tissue
tissue adhesive
application tool
nozzle
chemical liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001323890A
Other languages
Japanese (ja)
Inventor
Masao Ikeda
昌夫 池田
Yukihiko Sakaguchi
幸彦 坂口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Bakelite Co Ltd
Original Assignee
Sumitomo Bakelite Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Bakelite Co Ltd filed Critical Sumitomo Bakelite Co Ltd
Priority to JP2001323890A priority Critical patent/JP2003126268A/en
Publication of JP2003126268A publication Critical patent/JP2003126268A/en
Pending legal-status Critical Current

Links

Landscapes

  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Nozzles (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an applicator providing a strong adhesion for a biological tissue adhesive and reducing wasteful application to parts other than an affected region by sufficiently mixing sprays of an equal or different quantities of two or more biological tissue adhesives using a turning flow. SOLUTION: The biological tissue adhesive applicator is intended to spray a liquid medicine composed of a plurality of components, and has a means to generate the turning flow of a sterile gas, including all liquid medicine spray nozzles.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、主に複数成分系製
剤として適用される組織接着剤の塗布用具に関するもの
であり、特に肝臓や肺の切除断端や消化管の縫合部の止
血閉鎖などに好適な、生体の患部に噴霧して塗布するた
めの生体組織接着剤塗布用具に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a device for applying a tissue adhesive, which is mainly applied as a multi-component preparation, and particularly to a hemostasis closure of a resected stump of the liver or lung or a sutured part of the digestive tract. The present invention relates to a biological tissue adhesive application tool suitable for spraying and applying to a diseased part of a living body.

【0002】[0002]

【従来の技術】繊維素原(フィブリノゲン)は、いわゆ
る血液凝固カスケードの最終段階に存在する非常に重要
な役割を担う凝固因子である。フィブリノゲンは、例え
ば損傷後の血液凝固系の活性化において、トロンビンに
より、その可溶性形態から止血及び創傷治療に重要な寄
与をする不溶性のフィブリンに変換される。この血液凝
固の最終相の原理を利用した組織接着剤が開発され、外
科手術において肝臓または脾臓のような軟部器官の縫合
代用の接着剤として、または縫合補助剤として使用され
ている。同時に、幅広い臨床の現場で応用されている。
一般にはシリンジに別々に収納されたフィブリノゲン溶
液およびトロンビン溶液を別々、または同時に適用部位
へ滴下する方法が取られていたが閉鎖効果が不十分であ
るため、簡易により高い閉鎖効果を得る方法として、1
流体ノズルによるスプレー法が考案され実用化されてい
るが、十分な閉鎖効果を得るまでには至っていない上、
詰まりの問題などもあり実用性に劣っていた。
BACKGROUND OF THE INVENTION Fibrinogen is a coagulation factor which plays a very important role in the final stage of the so-called blood coagulation cascade. Fibrinogen is converted by thrombin from its soluble form to insoluble fibrin, which makes an important contribution to hemostasis and wound healing, for example in the activation of the blood coagulation system after injury. Tissue adhesives utilizing the principle of this final phase of blood coagulation have been developed and used in surgery as adhesives for suture replacement of soft organs such as the liver or spleen, or as suture auxiliary agents. At the same time, it is applied in a wide range of clinical settings.
In general, the method of dropping the fibrinogen solution and the thrombin solution separately stored in a syringe separately, or at the same time, was applied dropwise to the application site, but since the closing effect is insufficient, as a method of easily obtaining a higher closing effect, 1
A spray method using a fluid nozzle has been devised and put into practical use, but it has not yet reached a sufficient closing effect.
It was inferior in practical use due to problems such as clogging.

【0003】これを改善する方法として、近年は2本の
シリンジに収納されたフィブリノゲン溶液およびトロン
ビン溶液を同時に射出し、無菌ガスを利用して、射出さ
せた2液を霧状に噴霧して混合するスプレー塗布法が普
及し始めている。このような器具の好適な例は、例えば
WO/947420号に開示されている。しかしなが
ら、このような複数の2流体平行型ノズルの並列による
混合スプレーには、各々の噴霧角度と位置関係により互
いに重複する塗布面積以外の混合効率が悪く薬液の無駄
も多いため、大血管の処置や、肺のエアーリークの処置
などの強い接着・閉鎖効果が求められる症例では、組織
接着剤が十分な効果を発揮するまでにはなお克服するべ
き問題が存在した。
As a method for improving this, in recent years, a fibrinogen solution and a thrombin solution stored in two syringes are simultaneously injected, and the injected two solutions are atomized and mixed by using a sterile gas. The spray coating method is becoming popular. Suitable examples of such devices are disclosed, for example, in WO / 947420. However, in such a mixed spray in which a plurality of two-fluid parallel nozzles are arranged in parallel, mixing efficiency is poor except for the coating areas overlapping each other due to the respective spray angles and positional relationships, and a large amount of chemical liquid is wasted. In cases where strong adhesion and closure effects are required, such as treatment of air leaks in the lungs, there still existed problems to be overcome before the tissue adhesive exerts a sufficient effect.

【0004】一方、組織接着剤の効果を増強する方法と
してフィブリノゲン溶液とトロンビン溶液との混合比を
変更し、フィブリノゲン濃度を高めることが有効である
ことが実験的には確認されている。これらの組織接着剤
に適用する装置、すなわちフィブリノゲン溶液とトロン
ビン溶液とを異なる容量で同時に注入するための装置が
特開昭61−293443号公報、WO97−3363
3号公報、及び特開2000−262525号公報等に
開示されている。しかしながら塗布用具に関しては通常
の2本の薬液噴霧ノズルを持つ同じ容量の2成分薬液を
塗布するためのものが用いられており、吐出バランスが
不均一となるため十分な混合状態が得られない問題があ
った。すなわち2成分の薬液の容量が著しく異なる場
合、個々の薬液の吐出速度が大きく異なるため同時に2
液をミスト化するのが難しく、前記塗布法以上の不十分
な混合状態となってしまい、特に接着剤の硬化時間が延
長してしまうことがあった。
On the other hand, it has been experimentally confirmed that it is effective to increase the fibrinogen concentration by changing the mixing ratio of the fibrinogen solution and the thrombin solution as a method for enhancing the effect of the tissue adhesive. A device applied to these tissue adhesives, that is, a device for simultaneously injecting a fibrinogen solution and a thrombin solution in different volumes is disclosed in JP-A-61-293443 and WO97-3363.
It is disclosed in Japanese Patent No. 3 and Japanese Patent Laid-Open No. 2000-262525. However, as an application tool, an ordinary one having two chemical spray nozzles for applying the same volume of the two-component chemical solution is used, and the discharge balance becomes uneven, so that a sufficient mixed state cannot be obtained. was there. That is, when the volumes of the two component chemical liquids are significantly different, the discharge speeds of the individual chemical liquids are greatly different, so that the two liquids are simultaneously discharged.
It is difficult to form a mist of the liquid, resulting in an insufficiently mixed state beyond the above coating method, and in particular, the curing time of the adhesive may be extended.

【0005】この問題を解決するべく手段として、特開
2001−57979号公報に開示されているような異
なる容量の2液以上の薬液の吐出速度をより均一にする
ことにより薬液を無菌ガスの噴出により霧化して十分に
混合させるノズルなどが示されている。しかしながら、
基本的に2流体平行型ノズルを複数個配置した構造であ
るため、この方式のノズルが根本的に持つ各成分の霧の
混合効率の悪さ、すなわち各薬液噴霧ノズルの噴霧の塗
布重複部分以外の混合効率が悪く、言い換えれば無駄に
薬液を適用部以外へ塗布しているという問題が存在し
た。
As a means for solving this problem, as shown in JP 2001-57979 A, aseptic gas is ejected from the chemical solution by making the discharge rates of two or more chemical solutions of different volumes more uniform. Nozzles for atomizing and mixing sufficiently are shown by. However,
Basically, it has a structure in which a plurality of two-fluid parallel nozzles are arranged. Therefore, the poor mixing efficiency of the mist of each component, which is fundamentally possessed by this type of nozzle, that is, the parts other than the overlapping parts of spray application of each chemical spray nozzle There was a problem that the mixing efficiency was poor, in other words, the chemical liquid was wastedly applied to a portion other than the application portion.

【0006】[0006]

【発明が解決しようとする課題】本発明は、従来のこの
ような問題点を解決することを目的とするもので、等
量、もしくは異なる容量の2液以上の薬液の噴霧を旋回
流を利用して十分に混合させることにより、高強度の組
織接着剤を塗布可能であり、加えて適用部以外への無駄
な塗布の底減が可能な用具を提供するものである。
SUMMARY OF THE INVENTION The present invention is intended to solve the above-mentioned conventional problems, and utilizes a swirling flow to spray two or more liquid chemicals of equal or different volumes. By providing sufficient mixing, a high-strength tissue adhesive can be applied, and in addition, a tool that can reduce wasteful application bottoms other than the application part is provided.

【0007】[0007]

【課題を解決するための手段】即ち本発明は、(1)複
数成分の薬液を噴霧するための塗布用具において、薬液
噴霧ノズルを包含する無菌ガスの旋回流を発生させる手
段を設けたことを特徴とする生体組織接着剤塗布用具、
(2)旋回流を発生させる手段が、薬液噴霧ノズルを包
含する円周上に設けられた複数の無菌ガス流通路よりな
り、無菌ガス噴出口直前までの無菌ガス流通路が、噴霧
方向の軸に対し、全て同じ方向に傾けられたほぼらせん
形状よりなる(1)記載の生体組織接着剤塗布用具、
(3)塗布用具には後端に複数の薬液注入口、中央付近
に無菌ガス注入口、更に先端には薬液注入口と薬液流通
路を介して連通する複数の薬液噴霧ノズルが設けられて
いる(1)又は(2)記載の生体組織接着剤塗布用具、
(4)各薬液噴霧ノズルが、薬液吐出口と該薬液吐出口
に対してほぼ同軸且つ外側にほぼ環状に配置された無菌
ガス噴出口からなる2流体平行型ノズルである(3)記
載の生体組織接着剤塗布用具、(5)各薬液噴霧ノズル
が微細孔よりなる1流体ノズルである(3)記載の生体
組織接着剤塗布用具である。
Means for Solving the Problems That is, according to the present invention, (1) a coating tool for spraying a chemical liquid of a plurality of components is provided with a means for generating a swirl flow of a sterile gas including a chemical liquid spray nozzle. Characteristic biological tissue adhesive application tool,
(2) The means for generating a swirl flow is composed of a plurality of sterile gas flow passages provided on the circumference including the chemical liquid spray nozzle, and the sterile gas flow passage up to immediately before the sterile gas ejection port has an axis in the spray direction. On the other hand, the living tissue adhesive application tool according to (1), which has a substantially spiral shape inclined in the same direction,
(3) The application tool is provided with a plurality of drug solution inlets at the rear end, a sterile gas inlet near the center, and a plurality of drug solution spray nozzles communicating with the drug solution inlets through the drug solution flow passages at the tip. The biological tissue adhesive application tool according to (1) or (2),
(4) The living body according to (3), wherein each chemical liquid spray nozzle is a two-fluid parallel type nozzle including a chemical liquid discharge port and a sterile gas jet port arranged substantially coaxially with the chemical liquid discharge port and substantially annularly outside thereof. Tissue adhesive application tool, (5) The biological tissue adhesive application tool according to (3), wherein each chemical solution spray nozzle is a one-fluid nozzle having fine holes.

【0008】[0008]

【発明の実施の形態】以下、図面をもとに本発明につい
て詳細に説明する。図1は本発明の一実施例の外観を示
す図で、図2はノズルの一実施例の拡大図で、(a)は
分解図及び(b)は組立後の図である。図3は噴霧時の
スプレーヘッド(1)の断面図で、同じく図4は噴霧時
のノズル(2)の断面拡大図である。(a)は本発明に
よる噴霧状態の一実施例で、(b)は従来の噴霧の状態
を示したものである。また、図5(a)〜(d)は本発
明の旋回流発生装置の実施例の一部を示した図であり、
図6は本発明に適用可能な薬液噴霧ノズルの構造の一実
施例を示したもので、(a)は無菌ガスを用いて噴霧と
する2流体平行型ノズル、(b)は無菌ガスを使用せず
に薬液の加圧のみで噴霧を行う1流体ノズルの一実施例
を示したものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention will be described in detail below with reference to the drawings. 1 is an external view of an embodiment of the present invention, FIG. 2 is an enlarged view of an embodiment of a nozzle, (a) is an exploded view and (b) is a view after assembly. 3 is a sectional view of the spray head (1) during spraying, and FIG. 4 is an enlarged sectional view of the nozzle (2) during spraying. (A) is an example of a spray state according to the present invention, and (b) shows a conventional spray state. 5A to 5D are views showing a part of the embodiment of the swirl flow generating device of the present invention,
FIG. 6 shows an embodiment of the structure of a chemical spray nozzle applicable to the present invention. (A) is a two-fluid parallel nozzle for spraying using sterile gas, (b) uses sterile gas. FIG. 3 shows an example of a one-fluid nozzle that sprays only by pressurizing a chemical liquid without performing.

【0009】図1は本発明の一実施例で、前述のように
フィブリノゲン溶液及びトロンビン溶液を別々に充填し
たシリンジ(6)をホルダー1(7),ホルダー2
(8)にセットし、ホルダー2(8)を押すことで同時
にノズル(2)より噴霧される。ノズル(2)は薬液を
霧状にする目的の薬液噴霧ノズル(9)と、薬液噴霧ノ
ズル(9)で生成した霧を包み込み混合させるための旋
回流をつくる旋回流発生装置から構成される。
FIG. 1 shows an embodiment of the present invention, in which a syringe (6) separately filled with a fibrinogen solution and a thrombin solution as described above is provided in a holder 1 (7) and a holder 2
It is sprayed from the nozzle (2) at the same time by setting it in (8) and pressing the holder 2 (8). The nozzle (2) is composed of a chemical liquid spray nozzle (9) for atomizing the chemical liquid, and a swirl flow generation device that creates a swirl flow for enclosing and mixing the mist generated by the chemical liquid spray nozzle (9).

【0010】更に詳細には図3に示すように、薬液噴霧
ノズル(9)は薬液吐出口(10)と薬液吐出口(1
0)周りにほぼ環状に配置された無菌ガス噴出口(1
1)から成る2つの2流体平行型ノズルを有した形態の
スプレーであり、各薬液と無菌ガスの流通路の関係は図
3に示すように完全に独立しており、無菌ガスは無菌ガ
ス注入口(4)からスプレーヘッド(1)内を通り、各
無菌ガス噴出口(11)より外部へと噴出する。無菌ガ
ス噴出口(11)は完全な環状である必要はなく、薬液
吐出口(10)をほぼ同軸に固定しておくためのリブ等
によって区切られていても問題はないが、無菌ガス噴出
口(11)の開口面積の合計よりも同一環状内のリブの
面積の合計のほうが大きい場合は噴霧の粒子が粗くなる
ことが懸念され好ましくなく、無菌ガス噴出口(11)
の開口面積の合計のほうが大きいことが好ましい。更に
好ましくは、無菌ガス噴出口の合計面積:リブ合計面積
=2:1以上である。また、このリブは等間隔で整然と
配置されることが好ましい。
More specifically, as shown in FIG. 3, the chemical spray nozzle (9) has a chemical discharge port (10) and a chemical discharge port (1).
0) Aseptic gas jets (1
1) is a spray having two parallel two-fluid nozzles, and the relationship between each drug solution and the aseptic gas flow passage is completely independent as shown in FIG. It passes through the inside of the spray head (1) from the inlet (4) and is jetted to the outside from each sterile gas jet (11). The aseptic gas jet (11) does not have to be a perfect ring, and there is no problem if it is separated by a rib or the like for fixing the chemical liquid outlet (10) almost coaxially, but the sterile gas jet (11) If the total area of the ribs in the same ring is larger than the total area of the openings of (11), it is not preferable because the particles of the spray may become coarse, which is not preferable.
It is preferable that the total of the opening areas is larger. More preferably, the total area of aseptic gas jets: total rib area = 2: 1 or more. Further, it is preferable that the ribs are regularly arranged at equal intervals.

【0011】一方、各薬液は各々の薬液注入口(3)よ
り注入され、薬液流通路(13)内を通り薬液吐出口
(10)より外部へと吐出されるものである。図2に示
す本実施例の旋回流発生装置は、全ての薬液噴霧ノズル
(9)を包含するほぼ環状線上にほぼ等間隔で配置した
複数の旋回流生成ノズル(12)の集合体で、噴霧軸に
ほぼ軸対象に噴霧軸に対して角度を設けたほぼらせん形
状を呈する無菌ガス流通路(14)の集合より成る。こ
の旋回流生成ノズル(12)より噴出した無菌ガスは噴
霧軸方向に対して回転方向成分を持ちつつ前進する円筒
状の回転する流れ、所謂旋回流を生成するため、これに
内包される各薬液噴霧ノズル(9)により作られる霧は
互いによく混合され、塗布されることになる。
On the other hand, each chemical liquid is injected from each chemical liquid injection port (3), passes through the chemical liquid flow passage (13), and is discharged to the outside from the chemical liquid discharge port (10). The swirl flow generator of the present embodiment shown in FIG. 2 is an assembly of a plurality of swirl flow generation nozzles (12) arranged at approximately equal intervals on a substantially annular line including all the chemical liquid spray nozzles (9), and spraying is performed. It consists of a collection of sterile gas flow passages (14) of substantially spiral shape, with the axis being substantially symmetrical with respect to the spray axis. The sterile gas ejected from the swirl flow generation nozzle (12) generates a so-called swirl flow, which is a cylindrical rotating flow advancing while having a rotational direction component with respect to the spray axis direction. The mist produced by the spray nozzles (9) will be well mixed with each other and applied.

【0012】より詳細には、図2(a)に示すようにノ
ズル(2)を形成する円筒状の部品の外周にほぼらせん
形状の溝が配置されており、図2(b)に示すようにス
プレーヘッド(1)に嵌合することによりほぼらせん形
状の無菌ガス流通路(14)を形成する。この無菌ガス
流通路(14)の形や大きさなどは無菌ガスの種類や使
用時のガス圧、流量などを考慮し、適切な寸法形状とす
ることが望ましいものであり、図5(a)〜(d)に正
面図の例を示すように様々な寸法・形状が考えられる。
らせん形状の角度も同様に無菌ガスの種類や使用時のガ
ス圧,流量、また噴霧する薬液の種類や吐出量などによ
り最適な旋回流を生成する形状とすることが望ましい。
More specifically, as shown in FIG. 2 (a), a substantially spiral groove is arranged on the outer periphery of a cylindrical part forming the nozzle (2), and as shown in FIG. 2 (b). The sterile gas flow passage (14) having a substantially spiral shape is formed by fitting with the spray head (1). It is desirable that the shape and size of the aseptic gas flow passage (14) have an appropriate size and shape in consideration of the type of aseptic gas, gas pressure and flow rate during use, and the like. Various sizes and shapes are conceivable as shown in the front view examples in FIGS.
Similarly, it is desirable that the angle of the spiral shape be a shape that produces an optimum swirl flow depending on the type of sterile gas, the gas pressure and flow rate during use, the type of sprayed chemical liquid, and the discharge amount.

【0013】本分野のスプレーはディスポーザブルであ
り、コスト面から簡易な構造が求められるものであるた
め、図2または図5に示すような構造が好ましいと考え
るが、これ以外の構造でも全ての薬液噴霧ノズルを包含
する旋回流を生成可能であればなんら問題はなく、例え
ば無菌ガス噴出口自体が回転する構造や、ファン等にて
旋回流を発生させる構造でも構わない。
Since the spray in this field is disposable and requires a simple structure from the viewpoint of cost, it is considered that the structure shown in FIG. 2 or 5 is preferable. There is no problem as long as a swirl flow including the spray nozzle can be generated. For example, a structure in which the sterile gas jet itself rotates or a structure in which a swirl flow is generated by a fan or the like may be used.

【0014】しかしながら、本発明は医療用途であるの
で、使用する部品の原材料は医療用に安全性の確認され
たものであることが求められる。特に限定されるもので
はないが、ディスポーザブルということを考慮すれば、
ABSやポリプロピレン、ポリエチレン等の医療用グレ
ードの樹脂であることが好ましく、加工、成形性、組立
性等を考慮し適切なものを選定すればよい。
However, since the present invention is for medical use, it is required that the raw materials of the parts to be used are those whose safety has been confirmed for medical use. Although it is not particularly limited, considering that it is disposable,
A medical grade resin such as ABS, polypropylene, or polyethylene is preferable, and an appropriate resin may be selected in consideration of processing, moldability, and assemblability.

【0015】以下、旋回流生成ノズル(12)の効果を
説明する。一般に旋回流と呼ばれる所謂渦巻き流は、こ
れに包含された物質を渦の中心軸の方向へと誘導する性
質が知られており、複数のガスまたは霧をこの旋回流へ
と投入すれば互いに旋回流の中心軸方向に集まりつつ混
合されることとなる。この旋回流による噴霧の状態を図
4(a)に示す。旋回流生成ノズル(12)による旋回
流は、薬液噴霧ノズル(9)を包含しているため霧の無
駄な拡散を防ぎ、且つ渦を巻いているため旋回流の中心
軸へ向けて霧を混合させると共に集中させるよう効果的
に働き、結果として薬液の塗布部位以外への無駄な噴霧
・塗布をなくすことが出来、本発明のノズル(2)では
極めて効率的に混合され、塗布面積も小さく押えること
が出来るため効率がよい。
The effect of the swirl flow generating nozzle (12) will be described below. The so-called swirl flow, which is generally called swirl flow, is known to induce the substances contained in it in the direction of the central axis of the swirl, and if multiple gases or mist are injected into this swirl flow, they swirl with each other. It will be mixed while gathering in the central axis direction of the flow. The state of spraying by this swirling flow is shown in FIG. Since the swirl flow generated by the swirl flow generation nozzle (12) includes the chemical liquid spray nozzle (9), wasteful diffusion of the mist is prevented, and since the swirl is swirled, the mist is mixed toward the central axis of the swirl flow. It effectively works to concentrate and concentrate, and as a result, it is possible to eliminate wasteful spraying / application of the chemical liquid to a portion other than the application site, and the nozzle (2) of the present invention mixes it very efficiently and holds down the application area small. Because it is possible, it is efficient.

【0016】これに対し、従来のスプレーでは図4
(b)に示すように霧は薬液噴霧ノズル(9)から離れ
るにしたがい拡散することとなり、中央付近の各薬液の
霧の重なる部位以外は各薬液の混合率が極めて低く各薬
液が混合されることはないため接着閉鎖効果を得られず
全くの無駄となっている。また、本実施例の旋回流発生
装置では、全ての旋回流生成ノズル(12)をほぼ環状
に覆うフード(15)を設けている。これにより旋回流
の乱れと広がりを整えて霧の混合効率を向上させるもの
であり、より塗布面積を小さくしたい場合などに設置す
ることが望ましい。フード(15)の突出寸法は目的と
する塗布面積により最適な寸法とすることが重要である
が、極端に長い場合には薬液のフード(15)内面への
付着など、塗布の効率上好ましくない状況が生じること
が懸念されることとなるため、薬液噴霧ノズル(9)と
の位置関係を考慮することが必要であり、以下に説明す
る薬液噴霧ノズルのタイプ別によって適切な寸法を検討
することが望ましい。
On the other hand, the conventional spray is shown in FIG.
As shown in (b), the mist diffuses as it moves away from the chemical spray nozzle (9), and the mixing ratio of the chemicals is extremely low except for the area near the center where the fog of the chemicals overlaps. Since it does not happen, the adhesive closing effect cannot be obtained and it is completely wasted. Further, in the swirl flow generating device of the present embodiment, the hood (15) that covers all the swirl flow generation nozzles (12) in a substantially annular shape is provided. This improves the mixing efficiency of the mist by adjusting the turbulence and spread of the swirling flow. It is desirable to install the swirling flow when the application area is desired to be further reduced. It is important to make the protruding size of the hood (15) an optimum size depending on the intended application area, but if it is extremely long, it is not preferable from the viewpoint of application efficiency such as adhesion of the chemical solution to the inner surface of the hood (15). It is necessary to consider the positional relationship with the chemical liquid spray nozzle (9) because there is a concern that a situation will occur. Consider appropriate dimensions according to the type of chemical liquid spray nozzle described below. Is desirable.

【0017】旋回流発生装置により従来よりも霧が無駄
なく効率的に混合され得るので、薬液の霧化には図6
(a)に例を示す2流体平行型ノズルを用いなくとも、
図6(b)に示すような微細孔(16)より加圧した薬
液を噴出させ霧にする一般的な加圧式の1流体ノズルを
利用した薬液噴霧ノズルであっても問題はなく、また2
流体直行型ノズル等のその他の如何なる噴霧装置の原理
を用いてもよい。しかし、より簡易且つ確実に高強度の
接着閉鎖効果を望むのであれば、比較的低圧領域にて霧
の粒子が細かく良好な霧を得られる図6(a)のタイプ
の薬液噴霧ノズルを選択することが好ましい。また、非
等量の薬液噴霧を行う例であれば、3つや4つの複数の
薬液吐出口や、数だけでなく薬液吐出口の開口面積を適
切に配分した非等量に特化した薬液噴霧ノズルを用いる
と、更に高強度の接着閉鎖効果を得ることができ、効果
的でより好ましい。
Since the swirl flow generator can mix the fog more efficiently than before, it is necessary to atomize the chemical liquid as shown in FIG.
Even if the two-fluid parallel nozzle shown in (a) is not used,
There is no problem even with a chemical spray nozzle using a general pressure type one-fluid nozzle that sprays a chemical liquid pressurized from fine holes (16) as shown in FIG.
Any other atomizing device principle such as a fluid orthogonal nozzle may be used. However, if a simpler and more reliable high-strength adhesive closing effect is desired, a chemical spray nozzle of the type shown in FIG. 6 (a) is selected, which produces fine mist with fine mist particles in a relatively low pressure region. It is preferable. Further, in the case of performing non-equal amounts of chemical liquid spray, a chemical liquid spray specialized in non-equal amounts in which not only the number of chemical liquid discharge ports of three or four but also the opening area of the chemical liquid discharge ports is appropriately distributed. The use of a nozzle is effective and more preferable because it can obtain a stronger adhesive closing effect.

【0018】[0018]

【発明の効果】以上に述べた如く、本生体組織接着剤塗
布用具を用いれば、全ての薬液噴霧ノズルを包含する無
菌ガスの旋回流により各薬液の混合効率を高めることが
出来、噴霧部位以外への無駄な塗布を削減出来るため、
高い接着閉鎖効果を得る組織接着剤の塗布用具として極
めて有用である。
As described above, when the present biological tissue adhesive application tool is used, the swirling flow of aseptic gas including all the drug solution spray nozzles can enhance the mixing efficiency of each drug solution, and it is possible to improve the mixing efficiency of each drug solution. Since it is possible to reduce unnecessary application to
It is extremely useful as a tissue adhesive application tool that achieves a high adhesive closing effect.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の一実施例となる生体組織接着剤塗布用
具の外観の一例を示す図である。
FIG. 1 is a diagram showing an example of an external appearance of a biological tissue adhesive application tool according to an embodiment of the present invention.

【図2】本発明の一実施例となる生体組織接着剤塗布用
具のノズルの拡大図で、(a)は分解図、(b)は組立
後の透過図である。
FIG. 2 is an enlarged view of a nozzle of a biological tissue adhesive application tool according to an embodiment of the present invention, (a) is an exploded view, and (b) is a transmission view after assembly.

【図3】本発明の一実施例となる生体組織接着剤塗布用
具の噴霧時の内部構造の一例を示す平面断面図である。
FIG. 3 is a plan cross-sectional view showing an example of the internal structure of the biological tissue adhesive application tool according to an embodiment of the present invention during spraying.

【図4】本発明の一実施例となる生体組織接着剤塗布用
具の噴霧時のノズルの断面拡大図であり、(a)は本発
明による噴霧状態の一例で、(b)は従来の噴霧の一例
を示したものである。
FIG. 4 is an enlarged cross-sectional view of a nozzle of a biological tissue adhesive application tool according to an embodiment of the present invention when spraying, (a) is an example of a spray state according to the present invention, and (b) is a conventional spray. It shows an example of.

【図5】本発明の一実施例となる生体組織接着剤塗布用
具の旋回流発生装置の例を示した図である。
FIG. 5 is a diagram showing an example of a swirling flow generating device of a biological tissue adhesive application tool according to an embodiment of the present invention.

【図6】本発明の一実施例となる生体組織接着剤塗布用
具の薬液噴霧ノズルの構造の一例を示したもので、
(a)は無菌ガスを用いて噴霧とする2流体平行型ノズ
ルの一例、(b)は無菌ガスを使用せずに薬液の加圧の
みで噴霧を行う1流体ノズルの一例を示した図である。
FIG. 6 shows an example of the structure of a chemical spray nozzle of a biological tissue adhesive application tool according to an embodiment of the present invention,
(A) is a diagram showing an example of a two-fluid parallel type nozzle that sprays using a sterile gas, and (b) is a diagram showing an example of a one-fluid nozzle that sprays only by pressurizing a chemical solution without using a sterile gas. is there.

【符号の説明】[Explanation of symbols]

1 スプレーヘッド 2 ノズル 3 薬液注入口 4 無菌ガス注入口 5 無菌フィルター 6 シリンジ 7 ホルダー1 8 ホルダー2 9 薬液噴霧ノズル 10 薬液吐出口 11 無菌ガス噴出口 12 旋回流生成ノズル 13 薬液流通路 14 無菌ガス流通路 15 フード 16 微細孔 1 spray head 2 nozzles 3 Chemical injection port 4 Aseptic gas inlet 5 aseptic filter 6 syringes 7 holder 1 8 holder 2 9 Chemical spray nozzle 10 Chemical outlet 11 Aseptic gas jet 12 Swirl flow generation nozzle 13 Chemical flow passage 14 Aseptic gas flow passage 15 Hood 16 fine holes

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C060 MM24 MM26 4C167 AA67 BB02 BB21 BB70 CC06 CC20 CC21 CC23 CC24 4F033 QA01 QB03X QB17 QD02 QD09 QD18 QD25 QE19 QF17X   ─────────────────────────────────────────────────── ─── Continued front page    F-term (reference) 4C060 MM24 MM26                 4C167 AA67 BB02 BB21 BB70 CC06                       CC20 CC21 CC23 CC24                 4F033 QA01 QB03X QB17 QD02                       QD09 QD18 QD25 QE19 QF17X

Claims (5)

【特許請求の範囲】[Claims] 【請求項1】 複数成分の薬液を噴霧するための塗布用
具において、薬液噴霧ノズルを包含する無菌ガスの旋回
流を発生させる手段を設けたことを特徴とする生体組織
接着剤塗布用具。
1. An application tool for spraying a drug solution of a plurality of components, wherein a means for generating a swirl flow of a sterile gas including a drug solution spray nozzle is provided and a biological tissue adhesive application tool.
【請求項2】 旋回流を発生させる手段が、薬液噴霧ノ
ズルを包含する円周上に設けられた複数の無菌ガス流通
路よりなり、無菌ガス噴出口直前までの無菌ガス流通路
が、噴霧方向の軸に対し、全て同じ方向に傾けられたほ
ぼらせん形状よりなる請求項1記載の生体組織接着剤塗
布用具。
2. The means for generating a swirl flow comprises a plurality of aseptic gas flow passages provided on the circumference including a chemical liquid spray nozzle, and the sterile gas flow passage immediately before the aseptic gas ejection port has a spray direction. The biological tissue adhesive application tool according to claim 1, wherein the biological tissue adhesive application tool has a substantially spiral shape inclined in the same direction with respect to the axis.
【請求項3】 塗布用具には後端に複数の薬液注入口、
中央付近に無菌ガス注入口、更に先端には薬液注入口と
薬液流通路を介して連通する複数の薬液噴霧ノズルが設
けられている請求項1又は2記載の生体組織接着剤塗布
用具。
3. The application tool has a plurality of chemical solution inlets at its rear end,
3. The biological tissue adhesive application tool according to claim 1, wherein a sterile gas injection port is provided near the center, and further a plurality of drug solution spray nozzles communicating with the drug solution injection port via the drug solution flow passage are provided at the tip.
【請求項4】 各薬液噴霧ノズルが、薬液吐出口と該薬
液吐出口に対してほぼ同軸且つ外側にほぼ環状に配置さ
れた無菌ガス噴出口からなる2流体平行型ノズルである
請求項3記載の生体組織接着剤塗布用具。
4. The two-fluid parallel type nozzle, wherein each chemical liquid spray nozzle is composed of a chemical liquid discharge port and a sterile gas jet port arranged substantially coaxially with the chemical liquid discharge port and substantially annularly outside thereof. A biological tissue adhesive application tool.
【請求項5】 各薬液噴霧ノズルが微細孔よりなる1流
体ノズルである請求項3記載の生体組織接着剤塗布用
具。
5. The biological tissue adhesive application tool according to claim 3, wherein each chemical solution spray nozzle is a one-fluid nozzle having fine holes.
JP2001323890A 2001-10-22 2001-10-22 Biological tissue adhesive applicator Pending JP2003126268A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001323890A JP2003126268A (en) 2001-10-22 2001-10-22 Biological tissue adhesive applicator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001323890A JP2003126268A (en) 2001-10-22 2001-10-22 Biological tissue adhesive applicator

Publications (1)

Publication Number Publication Date
JP2003126268A true JP2003126268A (en) 2003-05-07

Family

ID=19140712

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001323890A Pending JP2003126268A (en) 2001-10-22 2001-10-22 Biological tissue adhesive applicator

Country Status (1)

Country Link
JP (1) JP2003126268A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006122854A (en) * 2004-10-29 2006-05-18 Yoshino Kogyosho Co Ltd Two-liquid mixing type spray
US7441973B2 (en) 2006-10-20 2008-10-28 Ethicon Endo-Surgery, Inc. Adhesive applicator
US7658305B2 (en) 2006-10-25 2010-02-09 Ethicon Endo-Surgery, Inc. Adhesive applier with articulating tip
US7749235B2 (en) 2006-10-20 2010-07-06 Ethicon Endo-Surgery, Inc. Stomach invagination method and apparatus
US7833216B2 (en) 2006-11-08 2010-11-16 Ethicon Endo-Surgery, Inc. Fluid plunger adhesive dispenser
US7892250B2 (en) 2006-11-01 2011-02-22 Ethicon Endo-Surgery, Inc. Use of biosurgical adhesive on inflatable device for gastric restriction
US7914511B2 (en) 2006-10-18 2011-03-29 Ethicon Endo-Surgery, Inc. Use of biosurgical adhesive as bulking agent
US8603138B2 (en) 2006-10-04 2013-12-10 Ethicon Endo-Surgery, Inc. Use of an adhesive to treat intraluminal bleeding
US8608642B2 (en) 2010-02-25 2013-12-17 Ethicon Endo-Surgery, Inc. Methods and devices for treating morbid obesity using hydrogel
US8876844B2 (en) 2006-11-01 2014-11-04 Ethicon Endo-Surgery, Inc. Anastomosis reinforcement using biosurgical adhesive and device
JP2018065097A (en) * 2016-10-20 2018-04-26 株式会社アトマックス Multiple fluid mixing nozzle and method for mixing and spraying multiple fluids
WO2022098019A1 (en) * 2020-11-08 2022-05-12 부산대학교 산학협력단 Catheter talc-spraying module for transthoracic fibrin glue application procedure

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5762661U (en) * 1980-09-27 1982-04-14
JPH09112820A (en) * 1995-10-17 1997-05-02 Babcock Hitachi Kk Pulverized coal burner
JPH10244187A (en) * 1997-03-05 1998-09-14 Daido Steel Co Ltd Powder melting burner
JP2001057979A (en) * 1999-08-20 2001-03-06 Sumitomo Bakelite Co Ltd Adhesive applying tool for biological tissue

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5762661U (en) * 1980-09-27 1982-04-14
JPH09112820A (en) * 1995-10-17 1997-05-02 Babcock Hitachi Kk Pulverized coal burner
JPH10244187A (en) * 1997-03-05 1998-09-14 Daido Steel Co Ltd Powder melting burner
JP2001057979A (en) * 1999-08-20 2001-03-06 Sumitomo Bakelite Co Ltd Adhesive applying tool for biological tissue

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006122854A (en) * 2004-10-29 2006-05-18 Yoshino Kogyosho Co Ltd Two-liquid mixing type spray
US8603138B2 (en) 2006-10-04 2013-12-10 Ethicon Endo-Surgery, Inc. Use of an adhesive to treat intraluminal bleeding
US7914511B2 (en) 2006-10-18 2011-03-29 Ethicon Endo-Surgery, Inc. Use of biosurgical adhesive as bulking agent
US7441973B2 (en) 2006-10-20 2008-10-28 Ethicon Endo-Surgery, Inc. Adhesive applicator
US7749235B2 (en) 2006-10-20 2010-07-06 Ethicon Endo-Surgery, Inc. Stomach invagination method and apparatus
US7658305B2 (en) 2006-10-25 2010-02-09 Ethicon Endo-Surgery, Inc. Adhesive applier with articulating tip
US7892250B2 (en) 2006-11-01 2011-02-22 Ethicon Endo-Surgery, Inc. Use of biosurgical adhesive on inflatable device for gastric restriction
US8876844B2 (en) 2006-11-01 2014-11-04 Ethicon Endo-Surgery, Inc. Anastomosis reinforcement using biosurgical adhesive and device
US7833216B2 (en) 2006-11-08 2010-11-16 Ethicon Endo-Surgery, Inc. Fluid plunger adhesive dispenser
US8608642B2 (en) 2010-02-25 2013-12-17 Ethicon Endo-Surgery, Inc. Methods and devices for treating morbid obesity using hydrogel
JP2018065097A (en) * 2016-10-20 2018-04-26 株式会社アトマックス Multiple fluid mixing nozzle and method for mixing and spraying multiple fluids
WO2022098019A1 (en) * 2020-11-08 2022-05-12 부산대학교 산학협력단 Catheter talc-spraying module for transthoracic fibrin glue application procedure

Similar Documents

Publication Publication Date Title
CA2678428C (en) Spray applicator
US5116315A (en) Biological syringe system
JP2003126268A (en) Biological tissue adhesive applicator
CA2222426A1 (en) Wound sealant preparation and application device and method
JP2013543754A (en) Nebulizer for nasal treatment
US20030209612A1 (en) Spray head for applying a multi-component mixture
EP3500182B1 (en) Spray tips for simultaneous multi-directional delivery of dissimilar fluids
JP4360377B2 (en) Biological tissue adhesive applicator
JP3933880B2 (en) Biological tissue adhesive applicator
JP3960505B2 (en) Biological tissue adhesive applicator
JP3857059B2 (en) Biological tissue adhesive applicator
JP4141916B2 (en) Biological tissue adhesive applicator
JP2001190558A (en) Device for applying organism tissue adhesive
JP2000354797A (en) Utensil for applicating adhesive to living tissue
JP3830073B2 (en) Biological tissue adhesive applicator
WO2022131249A1 (en) Medicinal liquid injection device for living body
JPH08280808A (en) Nasal drug dispenser
JP4141944B2 (en) Biological tissue medicine supply device
JP3025775U (en) Two chemical mixture spray nozzle
EP4037576B1 (en) Dispensing systems and devices having anti-clogging spray tips for dispensing two or more fluids that react together
JP5321373B2 (en) Biological tissue adhesive applicator
JP3483250B2 (en) Bio adhesive spray nozzle
JP2018000560A (en) Applicator
JP2001269348A (en) Spray nozzle of organism adhesive
JP2003235977A (en) Organism tissue adhesive application tool

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040520

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20061101

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070105

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070508